These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2198186

  • 1. Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.
    Paolisso G, Buonocore S, Gentile S, Sgambato S, Varricchio M, Scheen A, D'Onofrio F, Lefèbvre PJ.
    Diabetologia; 1990 May; 33(5):272-7. PubMed ID: 2198186
    [Abstract] [Full Text] [Related]

  • 2. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
    Paolisso G, Sgambato S, Giunta R, Varricchio M, D'Onofrio F.
    Diabete Metab; 1990 May; 16(1):42-7. PubMed ID: 2332096
    [Abstract] [Full Text] [Related]

  • 3. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

  • 4. Failure of glucagon to stimulate ketone body production during acute insulin deficiency or insulin replacement in man.
    Sonnenberg GE, Stauffacher W, Keller U.
    Diabetologia; 1982 Aug; 23(2):94-100. PubMed ID: 6127275
    [Abstract] [Full Text] [Related]

  • 5. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
    Avogaro A, Valerio A, Gnudi L, Maran A, Miola M, Duner E, Marescotti C, Iori E, Tiengo A, Nosadini R.
    Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
    [Abstract] [Full Text] [Related]

  • 6. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L, Alberti KG, Mengel A, Møller N, Pedersen O, Rasmussen O, Seefeldt T, Schmitz O.
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [Abstract] [Full Text] [Related]

  • 7. The metabolic effects of dopamine in man.
    Pernet A, Hammond VA, Blesa-Malpica G, Burrin J, Orskov H, Alberti KG, Johnston DG.
    Eur J Clin Pharmacol; 1984 Jul; 26(1):23-8. PubMed ID: 6143668
    [Abstract] [Full Text] [Related]

  • 8. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE, Perfetti MG, Andreotti AC, Fattor B, Monti LD, Pozza G.
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [Abstract] [Full Text] [Related]

  • 9. Contribution of cortisol to glucose counterregulation in humans.
    De Feo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, Brunetti P, Gerich JE, Bolli GB.
    Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
    [Abstract] [Full Text] [Related]

  • 10. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
    Pal BR, Phillips PE, Matthews DR, Dunger DB.
    Diabetologia; 1992 Jun; 35(6):542-9. PubMed ID: 1612227
    [Abstract] [Full Text] [Related]

  • 11. Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man.
    Keller U, Schnell H, Girard J, Stauffacher W.
    Diabetologia; 1984 Feb; 26(2):103-8. PubMed ID: 6143702
    [Abstract] [Full Text] [Related]

  • 12. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE.
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [Abstract] [Full Text] [Related]

  • 13. Some hormonal influences on glucose and ketone body metabolism in normal human subjects.
    Johnston DG, Pernet A, McCulloch A, Blesa-Malpica G, Burrin JM, Alberti KG.
    Ciba Found Symp; 1982 Jun; 87():168-91. PubMed ID: 6122546
    [Abstract] [Full Text] [Related]

  • 14. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS, Shelgikar KM, Naik SS, Kanitkar SV, Orskov H, Alberti KG, Hockaday TD.
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [Abstract] [Full Text] [Related]

  • 15. Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man.
    Verdin E, Castillo M, Luyckx AS, Lefebvre PJ.
    Diabetes; 1984 Dec; 33(12):1169-74. PubMed ID: 6389233
    [Abstract] [Full Text] [Related]

  • 16. Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.
    Giugliano D, Passariello N, Torella R, Cerciello T, Varricchio M, Sgambato S.
    Acta Diabetol Lat; 1981 Dec; 18(1):27-36. PubMed ID: 7211088
    [Abstract] [Full Text] [Related]

  • 17. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC, Hirsch IB, Smith LJ, Parvin CA, Holloszy JO, Cryer PE.
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [Abstract] [Full Text] [Related]

  • 18. Lipolytic and metabolic response to glucagon in fasting king penguins: phase II vs. phase III.
    Bernard SF, Thil MA, Groscolas R.
    Am J Physiol Regul Integr Comp Physiol; 2003 Feb; 284(2):R444-54. PubMed ID: 12388477
    [Abstract] [Full Text] [Related]

  • 19. The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle.
    Nosadini R, Alberti KG, Johnston DG, Del Prato S, Marescotti C, Duner E.
    Metabolism; 1981 Jun; 30(6):563-7. PubMed ID: 6112656
    [Abstract] [Full Text] [Related]

  • 20. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA.
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.